Saba Capital Management’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,407
Closed -$377 590
2023
Q3
$377 Hold
15,407
﹤0.01% 570
2023
Q2
$332 Hold
15,407
﹤0.01% 624
2023
Q1
$347 Hold
15,407
﹤0.01% 763
2022
Q4
$624 Buy
15,407
+8
+0.1% ﹤0.01% 905
2022
Q3
$1K Buy
+15,399
New +$1.09K ﹤0.01% 1107

Other funds holding VHAQ.WS

Saba Capital Management's VHAQ.WS Position: Q4 2023 in Review

Saba Capital Management sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q4 2023, closing a stake of 15,407 shares — an estimated $377 sold.

Saba Capital Management first reported a position in VHAQ.WS in Q3 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 6 funds tracked by Wall St. Rank hold VHAQ.WS as of Q4 2023.

  • Saba Capital Management reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q4 2023 after selling out during the quarter.
  • Saba Capital Management sold 15,407 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q4 2023, an estimated $377.
  • Saba Capital Management first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q3 2022 and held it in 5 quarters.
  • Saba Capital Management's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $1K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q4 2023.

Based on Saba Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.